rac-Trans-2-((4-((Ethyl(4-fluorophenyl)amino)methyl)-6-methyl-2-oxopyridin-1(2H)-yl)methyl)cyclopropane-1-carbonitrile

ID: ALA5266998

Chembl Id: CHEMBL5266998

Max Phase: Preclinical

Molecular Formula: C20H22FN3O

Molecular Weight: 339.41

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(Cc1cc(C)n(C[C@@H]2C[C@H]2C#N)c(=O)c1)c1ccc(F)cc1

Standard InChI:  InChI=1S/C20H22FN3O/c1-3-23(19-6-4-18(21)5-7-19)12-15-8-14(2)24(20(25)9-15)13-17-10-16(17)11-22/h4-9,16-17H,3,10,12-13H2,1-2H3/t16-,17-/m0/s1

Standard InChI Key:  DGIGAYPQXQSHGW-IRXDYDNUSA-N

Alternative Forms

  1. Parent:

    ALA5266998

    ---

Associated Targets(Human)

GRIN2A Tclin Glutamate [NMDA] receptor subunit epsilon 1 (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA2 Tclin Glutamate receptor ionotropic, AMPA 2 (847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 339.41Molecular Weight (Monoisotopic): 339.1747AlogP: 3.48#Rotatable Bonds: 6
Polar Surface Area: 49.03Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.86CX LogP: 2.57CX LogD: 2.57
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.81Np Likeness Score: -1.57

References

1. Yukawa T, Yamashita T, Imaeda T, Kakei H, Hashizume S, Nakamura M, Daini M, Okabe A, Nakashima K, Harada A, Narita N, Bettini E, Ugolini A, Corsi M, Hasui T..  (2023)  Design and synthesis of 6-methylpyridin-2-one derivatives as novel and potent GluN2A positive allosteric modulators for the treatment of cognitive impairment.,  79  [PMID:36640594] [10.1016/j.bmc.2022.117150]
2. Yukawa T, Yamashita T, Imaeda T, Kakei H, Hashizume S, Nakamura M, Daini M, Okabe A, Nakashima K, Harada A, Narita N, Bettini E, Ugolini A, Corsi M, Hasui T..  (2023)  Design and synthesis of 6-methylpyridin-2-one derivatives as novel and potent GluN2A positive allosteric modulators for the treatment of cognitive impairment.,  79  [PMID:36640594] [10.1016/j.bmc.2022.117150]

Source